Yuanqiong Hu, a senior legal and policy advisor at Doctors without...
Category:
Non-Life
Latest
Passenger vehicle wholesales in slow lane in May due to high base effect elections
The overall passenger vehicle dispatches from companies to dealers...
Govt shortlists 5 candidates for member, Non-Life, IRDAI, interview on June10
Five candidates are Rejeshwri Singh, CMD, National Insurance...
India’s urban affluent hit by new virus wave after dodging first
With the so-called consuming class ravaged by the new wave, India’s growth is at risk because private consumption accounts for about 60% of India’s economy. The central bank’s consumer confidence survey is showing increasing pessimism on jobs and policy makers have said they stand ready to support growth in what is now the world’s epicenter of the pandemic.
Only online registration for 18-45 age group to get Covid jab, says Centre
Sharma noted that the COWIN platform has now stabilized and is working at scale flawlessly. It is equipped to handle the complexities of the new phase of vaccination starting from 1st May.
With regards to the Phase-3 vaccination strategy from May 1, the states were advised to register additional private COVID-19 Vaccination Centres (CVCs) on mission mode by engaging with private hospitals, hospitals of industrial establishments, industry associations, etc., the health ministry said in a statement.
Delhi HC calls second wave as tsunami, asks Centre about preparedness to deal with peak
“We are calling it a wave, it is actually a tsunami, the court said, and asked the Centre about the preparedness in terms of infrastructure, hospitals, medical staff, medicines, vaccines and oxygen as on date for the peak,” said the court.
Solicitor General Tushar Mehta, representing the Centre, said there might be a rapid rise in the number of cases in May and June and the country needs to be ready for the worst.
Bharat Biotech prices Covaxin at Rs 600 for states, Rs 1,200 for pvt hospitals
”We would like to state that more than 50 per cent of our capacities have been reserved for Central Government supplies,” Ella said.
Earlier this week, the Serum Institute of India (SII) had announced a price of Rs 400 per dose for ”Covishield” for state governments and Rs 600 per dose for private hospitals.
India adds record over 3.49 lakh new COVID-19 cases in single day, 2,767 fatalities
India has now become the fastest country in the world to cross the landmark of 14 crore COVID-19 vaccine doses in just 99 days, said the Union Health Ministry.The number of people who have recuperated from the disease surged to 1,40,85,110, while the case fatality rate has further dropped to 1.13 per cent, the data stated.
Japan to issue 3rd virus emergency in Tokyo, Osaka area
Japan’s third state of emergency since the pandemic began comes only a month after an earlier emergency ended in the Tokyo area. For days, experts and local leaders said ongoing semi-emergency measures have failed and tougher steps are urgently needed.
Govt to provide free food grains to around 80 crore beneficiaries under PM Garib Kalyan Ann Yojana for May, June
The Government of India would spend more than Rs 26,000 crore on this initiative. This government’s initiative comes as India has seen a record surge in COVID-19 cases in the past few days. India recorded 3,32,730 new COVID-19 cases in the last 24 hours, the highest single-day spike since the pandemic broke out last year. India has crossed the mark of 3 lakh COVID-19 cases for two consecutive days now.
India closer to building world’s biggest nuclear plant: EDF
It faced opposition from local inhabitants since the idea was first floated around 20 years ago, and was delayed after the 2011 nuclear disaster in Fukushima, Japan.
Earthquake risks and the potential impact on local fishing have been cited as key issues.
Govt issues updated clinical guidance for management of Covid-19 patients
Under emergency use authorisation (EUA), remdesivir may be considered for only those patients with moderate to severe diseases (requiring supplemental oxygen) within 10 days of onset of symptoms.
It is not recommended for those with severe renal impairment or hepatic dysfunction, the guidelines stated.
“Not to be used in patients who are not on oxygen support or in home settings,” the ministry underlined.
Remdesivir production will be up from 38.80 lakh units/month to 74 lakh units/month by May: MHA
“The supply of Remdesivir injection and imported drug Tocilizumab is under severe constraint due to sharp increase in demand. Several steps have been taken to augment the production capacity of the seven licensed manufacturers of Remdesivir injection in the country from 38.80 lakh units per month to 74 lakh units per month by early May 2021,” said Union Home Secretary Ajay Bhalla, in a letter to chief secretaries of all states and Union territories (UTs)